fbpx

Oncology Institute Inc

TOI

$0.19

Closing

▼-5.46%

1D

▼-90.49%

YTD

TOI

BBG00S5H21J0

Exchange

Sector

Market cap

$14.66M

Volume

123,720

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$14.66M

Analysts' Rating

STRONG BUY

Price Target (Mean)

2.00

Total Analysts

1

P/E

Operating Margin

-16.60%

Beta

0.43

Revenue Growth

22.88%

52 week high

$2.48

52 week low

$0.13

Div. Yield

%

EPS Growth

-22.73

Company Profile

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company’s segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.